Hydrogen sulfide has recently been found decreased in chronic kidney disease. Here we determined the effect and underlying mechanisms of hydrogen sulfide on a rat model of unilateral ureteral obstruction. Compared with normal rats, obstructive injury decreased the plasma hydrogen sulfide level. Cystathionine-b-synthase, a hydrogen sulfideproducing enzyme, was dramatically reduced in the ureteral obstructed kidney, but another enzyme cystathionine-c-lyase was increased. A hydrogen sulfide donor (sodium hydrogen sulfide) inhibited renal fibrosis by attenuating the production of collagen, extracellular matrix, and the expression of a-smooth muscle actin. Meanwhile, the infiltration of macrophages and the expression of inflammatory cytokines including interleukin-1b, tumor necrosis factor-a, and monocyte chemoattractant protein-1 in the kidney were also decreased. In cultured kidney fibroblasts, a hydrogen sulfide donor inhibited the cell proliferation by reducing DNA synthesis and downregulating the expressions of proliferation-related proteins including proliferating cell nuclear antigen and c-Myc. Further, the hydrogen sulfide donor blocked the differentiation of quiescent renal fibroblasts to myofibroblasts by inhibiting the transforming growth factor-b1-Smad and mitogen-activated protein kinase signaling pathways. Thus, low doses of hydrogen sulfide or its releasing compounds may have therapeutic potentials in treating chronic kidney disease.
Tubulointerstitial fibrosis is the final common pathway to chronic kidney diseases (CKD). 1 Pathologically, renal fibrosis manifests as the formation of myofibloblasts and the deposition of extracellular matrix proteins in the renal interstitium. 2 The mechanisms of renal fibrosis have not been fully elucidated and effective drugs are still scarce. Renin-angiotensin-aldosterone system is one of the main culprits of renal fibrogenesis, and renin-angiotensinaldosterone system inhibitors remain the first-line drugs in fighting renal fibrosis. 3 However, the renin-angiotensinaldosterone system inhibitors may deteriorate renal function and cause hyperpotassemia when serum creatinine rises above 3 mg/dl. 4 New antifibrotic agents are therefore needed to expand therapeutic options and decrease side effects, which is especially important for azotemia patients.
Hydrogen sulfide (H 2 S) represents the third gasotransmitter along with nitric oxide and carbon monoxide. 5 It is generated by cystathionine-g-lyase (CSE), cystathionine-bsynthase (CBS), and 3-mercaptopyruvate sulphurtransferase. CBS and CSE are enriched in renal proximal tubules and produce H 2 S in kidney in a combined way. 6 H 2 S plays various physiological and pathological roles in the kidney. For instance, it exhibits diuretic, natriuretic, and kaliuretic properties by increasing glomerular filtration rate and functions as an oxygen sensor in the renal medulla. 6, 7 Recently, it was reported that plasma H 2 S level was decreased in 5/6 nephrectomy rat and uremia patients, 8, 9 suggesting that uremic toxin of CKD impairs the production of endogenous H 2 S.
Notably, the biological functions of H 2 S in CKD are not fully understood. Heterozygous cbs À / À mice with unilateral nephretomy, an animal model of CKD, developed proteinuria and collagen deposition, and increased the expressions of matrix metalloproteinase-2 and -9. 10 Emerging evidence also demonstrates that H 2 S exhibits antifibrotic effects in the lung, heart, and liver. [11] [12] [13] Furthermore, H 2 S bears some similarities to the other two gaseous molecules, nitric oxide and carbon monoxide, both of which protect the kidney from renal fibrosis. 14, 15 Taken together, we hypothesize that H 2 S may attenuate renal fibrosis.
In this study, we examined the effect of H 2 S on unilateral ureteral obstructive (UUO) animal model and defined its safe and effective dosage range. Furthermore, we investigated the roles of H 2 S in renal fibroblast proliferation and differentiation. The potential mechanisms were also explored. RESULTS CBS expression and plasma H 2 S levels are decreased in the obstructed kidney
To investigate whether endogenous H 2 S was involved in the pathogenesis of renal fibrosis, we examined the expression and activity of H 2 S-producing enzymes CBS and CSE, as well as plasma H 2 S levels. The CBS expression was nearly completely ablated by obstructive injury at day 14, whereas CSE was increased. In contrast, the expressions of CBS and CSE in the contralateral kidneys were not affected (Figure 1a -c). Moreover, H 2 S generation in the obstructed kidneys was dramatically reduced compared with shamoperated rats (Figure 1d ). Plasma H 2 S levels were reduced by B30% in UUO rats compared with the sham counterparts (27.5 ± 4.3 mmol/l vs. 39.4 ± 6.3 mmol/l, P ¼ 0.021, Figure 1e ). Immunohistochemistry staining indicated that CBS was predominantly expressed in proximal renal tubules. UUO injury time-dependently reduced CBS expression in the obstructed kidneys without affecting that in the contralateral and sham-operated kidneys (Figure 2a and b) . In contrast, CSE was mainly located in renal glomeruli, interstitium, and interlobular arteries of normal rats. UUO injury markedly increased the CSE expression in the interstitium of obstructed kidneys. The CSE expression in the unobstructed kidneys remained unchanged (Figure 2c and d) .
NaHS treatment decreases the renal size, increases the cortical thickness, and ameliorates renal function of UUO rats
To assess the effect of exogenous H 2 S supplement on renal fibrosis, we treated UUO rats with incremental doses of sodium hydrosulfide (NaHS; 5.6, 56, and 560 mg/kg/day) and CSE inhibitor (DL-propargylglycine (PAG), 25 mg/kg/day) via intraperitoneal injection once daily for 3 days before and 2 weeks after UUO injury. The renin-angiotensin-aldosterone system inhibitor enalapril (10 mg/kg/day) was also administrated via intragastria as a positive control. Gross appearance (Figure 2a ) and group data (Figure 2b and c) showed that enalapril and NaHS (56 mg/kg/day) reduced the size of the kidney and increased the renal cortical thickness in UUO rats. However, these effects were not observed in the rats treated with NaHS at a higher dose of 560 mg/kg/day or PAG (Figure 3 ). Compared with UUO rats, NaHS (56 mg/kg/day) decreased serum creatinine levels, whereas PAG increased serum urea nitrogen concentration. There were no differences of serum electrolytes among each group (Supplementary  Data and Supplementary Table S1 online).
NaHS attenuates renal tubulointerstitial injury and collagen deposition in renal interstitium
Hematoxylin and eosin staining results indicated that UUO rats exhibited dilated renal tubule, epithelial cells atrophy, interstitial expansion, and increased infiltration of inflammatory Masson trichrome staining demonstrated that UUO injury resulted in a significant accumulation of collagen fibrils (blue area) compared with the sham group. Enalapril and NaHS (5.6 and 56 mg/kg/day) attenuated the fibrotic lesions with less collagen deposited in the renal interstitium. In contrast, NaHS at 560 mg/kg/day and PAG increased the collagen production compared with that of the UUO group (Figure 4a and b).
NaHS inhibits the expression of SMA and fibronectin in the obstructed kidney
To evaluate whether H 2 S reduced the production of myofibroblasts and extracellular matrix, the renal expression of a-smooth muscle actin (a-SMA) and fibronectin were detected on day 14 after UUO operation. Immunohistochemistry staining and semiquantitative analysis showed that enalapril and NaHS (5.6 and 56 mg/kg/day) decreased the expressions of a-SMA and fibronectin of the UUO rats. In contrast, NaHS 560 mg/kg/day and PAG increased the production of these proteins, but statistical difference was not obtained in the PAG group (Figure 5a-d) . These observations were verified by western blot analysis, in which NaHS, especially at the dose of 56 mg/kg/day, markedly reduced the expressions of a-SMA, fibronectin, phospho-Smad3, and transforming growth factor-b1 (TGF-b1) (Figure 6a-d) .
NaHS inhibits inflammation in the kidney after obstructive injury
The effect of H 2 S on the infiltration of inflammatory cells in obstructed kidneys was also determined at 7 days after UUO. CD68 (a macrophage marker) staining in renal cortex revealed an increased macrophage infiltration in the renal interstitium of UUO rats. NaHS (5.6 and 56 mg/kg/day) and enalapril markedly reduced the number of macrophage in the interstitium against the UUO group. This effect was most pronounced in the NaHS (56 mg/kg/d)-treated group. Compared with the UUO group, NaHS at 560 mg/kg/day increased the number of macrophage in renal cortex, whereas PAG tended but failed to significantly increase the CD68-positive cell number (Figure 7a and b) .
To confirm the anti-inflammatory effect of NaHS, the mRNA levels of interleukin-1b, tumor necrosis factor-a, and monocyte chemoattractant protein-1 were determined by quantitative PCR. All these inflammatory molecules were increased by UUO injury. NaHS (5.6 and 56 mg/kg/day) and enalapril suppressed the expression of these cytokines, whereas NaHS at 560 mg/kg/day and PAG were unable to exhibit anti-inflammatory effects ( Figure 7c ).
NaHS suppresses the NRK-49F cell proliferation induced by fetal bovine serum (FBS)
We further performed an in vitro study to investigate the antiproliferation effect of H 2 S on renal fibroblast using NRK-49F cells. Cells were exposed to various concentrations (1-500 mmol/l) of NaHS for 30 min, followed by stimulation with 10% FBS for 24 h. Cells with serum-free medium were set as controls. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay showed the cell number was significantly increased after incubation with 10% FBS for 24 h (Po0.05, Figure 8a ). Preincubation with NaHS (10, 50, 100, and 500 mmol/l) reduced the cell number by 17.6%, 14.8%, 21.4%, and 16.2%, respectively. However, statistical difference was only reached in 100 mmol/l NaHS group and the dose-dependent effect was not observed. Furthermore, we continued to test whether H 2 S inhibited the DNA synthesis of renal fibroblast cells using bromodeoxyuridine (BrdU) incorporation assay. The DNA synthesis triggered by 10% FBS was significantly decreased by NaHS (100 mmol/l) before treatment (Figure 8b and c). To delineate the mechanism beneath the antiproliferation effect of H 2 S, the expression of proliferation-related genes, including proliferating cell nuclear antigen (PCNA) and c-Myc, was also assessed. Preincubation with 100 mmol/l NaHS consistently attenuated the expressions of PCNA and c-Myc proteins induced by 10% FBS stimulation for 24 h (Figure 8d-f) .
NaHS blocks the differentiation of quiescent renal fibroblasts to myofibroblasts
Because TGF-b1 is the most potent cytokine controlling the phenotype switch from renal fibroblasts to myofibroblasts, we investigated the effect of H 2 S on renal fibroblast activation induced by TGF-b1. Reverse transcription-PCR demonstrated that NaHS pretreatment inhibited the mRNA expressions of collagen I, a-SMA, and fibronectin induced by TGF-b1 (Figure 9a-d) . Western blot analysis also revealed a significant elevation of a-SMA and fibronectin expression in NRK-49F cells after TGF-b1 stimulation. These effects were essentially abolished by NaHS (Figure 9e and f) . 
NaHS abolishes the phosphorylation of the MAPKs and Smad3
TGF-b1-Smad and mitogen-activated protein kinase (MAPK) pathways are two critical signaling mechanisms implicated in renal fibrosis. We therefore examined the effects of H 2 S on the TGF-b1-induced phosphorylation of Smad3, p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK) with western blot analysis. TGF-b1 (2 ng/ml) triggered the phosphorylation of these proteins with distinct patterns. The phosphorylation of p38 peaked at 0.5 h after TGF-b1 stimulation, quicker than that of the other molecules. Specifically, phosphorylation of ERK and JNK peaked at 2 h after TGF-b1 exposure whereas Smad3 at 1 h (data not shown). Pretreatment with 100 mmol/l NaHS abolished the increase of Smad3 and MAPKs phosphorylation induced by TGF-b1 stimulation ( Figure 10 ).
DISCUSSION
UUO is a well-established animal model featured by progressive renal fibrosis and tubulointerstitial injury. In this study, we demonstrated that exogenous H 2 S suppressed collagen and extracellular matrix deposition in the UUO rats. We also identified that H 2 S blocked renal fibrosis via multiple mechanisms. It inhibited renal fibroblast proliferation by reducing DNA synthesis and downregulating the expressions of proliferation-related proteins. H 2 S also blocked cell differentiation by suppressing the TGF-b1-Smad and MAPK signal pathways. Besides, H 2 S inhibited the inflammatory process induced by UUO injury.
The association of H 2 S and renal fibrosis is not well defined. Our study demonstrated that plasma H 2 S levels and endogenous H 2 S production in the obstructed kidneys were decreased in UUO rats. As UUO model is devoid of any exogenous toxin, or a 'uremic' environment, 16 our finding implies that renal fibrosis per se could reduce the H 2 S generation. Our study further demonstrated that CBS was predominantly expressed in renal tubules whereas CSE was mainly located in glomeruli and interstitial vessels, consistent with a recent report. 17 UUO injury markedly decreased the expression of CBS but increased that of CSE in the renal interstitium. This finding is consistent with previous studies that CBS is more predisposed to decrease in kidney disease compared with CSE. For instance, CBS was decreased 6 weeks earlier than CSE in rat remnant kidney. 8 In renal ischemic-reperfusion rats, CBS was reduced as earlier as 6 h after reperfusion, 18 whereas CSE was increased by prolonged reperfusion for 24 h. 19 Hence, the increase of CSE observed in this study could be explained as a 'compensatory mechanism' to maintain the H 2 S level. As CSE is abundant in glomeruli, H 2 S may also be beneficial for glomerular diseases. A recent study by Lee et al. 20 confirms this notion that H 2 S is able to protect the renal glomerular epithelial cells from high glucose-induced injury, indicating the reduction of H 2 S is involved in diabetic nephropathy.
As the endogenous H 2 S production was reduced by UUO injury, it is logical to hypothesize that exogenous H 2 S supplementation could relieve renal fibrosis. We observed that the antifibrotic effect of NaHS started at 5.6 mg/kg/day, peaked at 56 mg/kg/day, but was reversed at 560 mg/kg/day. Our results were in line with a prior study in which the most effective NaHS dose on cardiac ischemia-reperfusion injury was 56 mg/kg/day. 21 Moreover, low doses of NaHS (78 and 392 mg/kg/day body weight, twice daily) also reduced pulmonary fibrosis induced by bleomycin. 11 Previous studies demonstrated that H 2 S level in vertebrate blood varied from 10-300 mmol/l by the methylene blue assay. 22, 23 Using a sensitive fluorescent probe, 24 we found the plasma H 2 S level in normal rat was B30-40 mmol/l, whereas its counterpart in the UUO rat was 20-30 mmol/l. Nevertheless, the precise determination of H 2 S in biological samples is still controversial. More sensitive techniques such as monobromobimane-based assay and quantum dot/nanoparticle methods recently indicated that blood and tissue H 2 S concentrations were as low as 0.15-0.9 mmol/l. 25, 26 These findings may justify the application of H 2 S at relatively low doses in treating renal fibrosis.
Although H 2 S is beneficial in most animal models of renal diseases, endogenous H 2 S has been reported detrimental in acute kidney injury caused by nephrotoxic drugs. For instance, the CSE inhibitor PAG (50 mg/kg/day) reduced the kidney damage of Wistar rats induced by cisplatin and adriamycin. 27, 28 This is inconsistent with our data in which PAG was unable to relieve renal fibrosis. In fact, 50 mg/kg/day PAG treatment resulted in a great weight loss of normal Sprague-Dawley rats in our study (data not shown), and the dose had to be lowered to 25 mg/kg/day. Such conflicting aspects of H 2 S implicate that diverse mechanisms of H 2 S may exist in different animal models and species. Despite this, caution must be taken in interpreting the effect of PAG because of its nonselective inhibitory action of CSE. It has been reported that D-amino acid oxidase and L-alanine transaminase can also be inhibited by PAG. 29, 30 Possibilities cannot be ruled out that the protective effect of PAG in renal disease may be mediated by inactivating other enzymes rather than CSE. Fibroblast proliferation and phenotypic transition to myofibroblast are two major cellular events of renal fibrosis. 31 FBS contains numerous growth factors that promote the proliferation and differentiation in many types of cells. The effect of H 2 S on cell proliferation seems to be cell specific. Some studies reported that H 2 S promoted the proliferation in rat intestinal epithelial cells and human colon cancer cells, whereas others demonstrated that it inhibited the proliferation of lung fibroblasts and pancreatic stellate cells. 32, 33 Our data revealed that NaHS at 100 mmol/l not only decreased the cell number, but also inhibited the DNA synthesis stimulated by FBS. These findings were further verified by the fact that NaHS downregulated the expressions of proliferation-related genes including PCNA and c-Myc. Previous studies also indicated that H 2 S induced DNA damage in many cell types. 34 The proliferation and cell cycle proteins such as p53, p21, and cyclin D1 were downregulated by H 2 S. 35, 36 Numerous cytokines and growth factors such as TGF-b1, platelet-derived growth factor, tissue plasminogen activator, and plasminogen activator inhibitor-1 are involved in the phenotypic switch of fibroblast to myofibroblast. [37] [38] [39] [40] Microarray analysis in an intestinal cell line suggests that TGF-b1 and MAPK kinases are regulated by H 2 S. 41 Our results showed that NaHS at 100 mmol/l suppressed mRNA and protein expressions of a-SMA and fibronectin induced by TGF-b1. In addition, H 2 S attenuated the phosphorylation of Smad3, a major pathway in the signal transduction of TGF-b1. These data suggested that H 2 S inhibited the fibroblast differentiation and extracellular matrix production partially by blocking the TGF-b1-Smad signaling. In addition to Smad-dependent pathway, MAPK kinases also engage in the effect of TGF-b1. ERK, p38, and JNK have been found to be activated in UUO model and regulate the proliferation, migration, and differentiation of fibroblast. 42 Our data indicated that H 2 S reversed the phosphorylation increase of p38, ERK, and JNK stimulated by TGF-b1 in renal interstitial fibroblasts, implying that the blockade of MAPK kinases activation may be another mechanism responsible for the antifibrotic effect of H 2 S.
Inflammation plays an important role in the priming and progression of renal fibrosis. 43 One of the pathological features of the UUO rat model is the marked infiltration of inflammatory cells in the renal interstitium. Substantial data support the anti-inflammation action of H 2 S in multiple organs and systems. 44 Our study echoed with these studies that H 2 S exhibited an anti-inflammatory property by reducing macrophage recruitment in renal interstitium. The inflammatory cytokines such as interleukin-1b, tumor necrosis factor-a, and monocyte chemoattractant protein-1 were also downregulated by NaHS. MAPKs are involved in modulating inflammatory processes. For example, JNK has been identified with the activation of macrophages and upregulation of proinflammatory mediators, and JNK inhibition resolves the inflammation. 45 Thus, the antiinflammatory effect of H 2 S may be mediated by inhibiting the MAPK signal pathway.
In summary, this study demonstrates for the first time that H 2 S exhibited antifibrotic effects on obstructed nephropathy and inhibited the proliferation and differentiation of renal fibroblasts both in vitro and in vivo. The antifibrotic mechanisms of H 2 S may involve its anti-inflammation as well as its blockade on TGF-b1 and MAPK signaling. This may provide a therapeutic option for renal fibrosis based on H 2 S modulation. Low dosage of H 2 S or its releasing compounds may have therapeutic potentials in treating CKD.
MATERIALS AND METHODS Reagents and antibodies
BrdU, PAG, enalapril, and NaHS, as well as antibodies against PCNA, c-Myc, and BrdU were purchased from Sigma-Aldrich (St Louis, MO). Recombinant human TGF-b1 and Trizol reagent were obtained from Invitrogen (Carlsbad, CA). Antibodies against a-SMA, fibronectin, CBS, and ERK/phosphorylated-ERK were from Santa Cruz Biotechnology (Santa Cruz, CA). CSE antibody was purchased from Abnova Chemical (Taiwan, China). Other antibodies unless specified were from Cell Signaling Technology (Danvers, MA).
Animal surgery and experimental protocols
Male Sprague-Dawley rats (180-200 g) were purchased from Shanghai Laboratory Animal Commission (Shanghai, China). UUO operation was performed as described previously. 16 Rats were randomly divided into the following seven groups: sham, UUO, UUO with enalapril (10 mg/kg/day), UUO with three doses of NaHS (5.6, 56, and 560 mg/kg/day), and UUO with PAG (25 mg/kg/day). NaHS and PAG were given intraperitoneally once daily 3 days before surgery and continued for 1 to 2 weeks after operation. Enalapril was given via intragastria. UUO rats received vehicle (saline) treatment. All rats were killed at day 7 or 14 days after surgery. The kidneys were then harvested and plasma was collected accordingly. The experimental protocols were approved by the Institutional Animal Care and Use Committee of Soochow University.
Histological analysis and immunohistochemical staining
Kidney samples were fixed in 10% formalin, embedded in paraffin, and sectioned 4 mm thick. Sections were deparaffined and stained with Masson trichrome reagents and observed under a light microscope. Renal collagen (blue area) was semiquantitatively measured at Â200 magnification in 10 randomly selected fields from 4 animals using Image Pro-Plus 6.0 software (Bethesda, MD).
For immunohistochemical studies, renal sections were incubated with antibodies against a-SMA (1:50), fibronectin (1:50), and CD68 (1:50) overnight at 4 1C, and subsequently incubated with corresponding secondary antibodies at room temperature for 1 h. Peroxidase-Streptavidin-biotin complex (Vector Laboratories, Burlingame, CA) and diaminobenzidine (Sigma, St Louis, MO) was used to visualize the proteins. Ten randomly selected fields (Â200 magnifications for a-SMA and fibronectin, and Â400 magnifications for CD68) were photographed and measured by a blinded observer using Image Pro-Plus 6.0 software. Plasma H 2 S and tissue H 2 S synthesis measurement Plasma H 2 S level was detected using Dansyl azide (DNS-Az), a novel fluorescent H 2 S probe (kindly gifted by Professor Binghe Wang, Georgia State University) as described previously. 24 Briefly, DNS-Az stock solution (2.2 mmol/l) was added at 10 ml per well in a 96-well plate, followed by mixing with 100 ml plasma. Fluorescence was immediately measured by a fluorescent microplate reader (Tecan M200, Grodig, Austria) with an excitation at 360 nm and emission at 528 nm. Tissue H 2 S production measurement was performed as previously described. 46 In brief, the left kidney homogenates were mixed with 2 mmol/l pyridoxal 5 0 -phosphate and 10 mmol/l L-cysteine and 250 ml 10% trichloroacetic acid to reach a total volume of 750 ml. After incubation at 37 1C for 30 min, 250 ml 1% zinc acetate was added to trap H 2 S. Then, 133 ml of 20 mmol/l N,Ndimethyl-p-phenylenedi-amine sulfate in 7.2 mol/l HCl and 133 ml of 30 mmol/l FeCl 3 in 1.2 mol/l HCl were added. The absorbance of the solution was determined at 670 nm with a spectrophotometer. The H 2 S concentration was calculated against a calibration curve of NaHS (0.1-100 mmol/l).
Cell culture and treatments
Normal rat kidney fibroblasts (NRK-49F) were purchased from American Type Culture Collection (Manassas, VA) and maintained in Dulbecco's modified Eagle's medium (4.5 g/l glucose) supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY). After preincubation with NaHS at various concentrations (1-500 mmol/l) for 30 min, recombinant human TGF-b1 (2 ng/ml) was added for various periods of time. In the control group, cells were treated with vehicle only. In proliferation studies, 10% FBS served as stimulators and the cells were subjected to serum-free medium for 24 h before experimentation.
Cell proliferation assay Cell proliferation was assessed by MTT assay and BrdU incorporation. For the MTT assay, cells (2Â10 3 /100 ml) were seeded in 96-well plate until subconfluence and quiescenced with serum-free medium for 24 h. Cells were then pretreated with NaHS (0.1-500 mmol/l) for 30 min, followed by incubation with or without 10% FBS for 24 h. MTT (0.5 mg/ml) was added at 4 h before treatment termination. At the end of treatment, medium was removed and dimethylsulfoxide at 150 ml per well was then added. Absorbance at 490 nm was measured by a microplate reader (Tecan M200).
For the BrdU incorporation, cells were seeded onto coverslips. After being pretreated with 100 mmol/l NaHS for 30 min, cells were incubated in medium with or without 10% FBS for 5 h, and pulsated with BrdU (10 mmol/l) for another 5 h. Next, cells were fixed in 4% paraformadehyde for 20 min and DNA was denatured with 2 N HCl at 37 1C for 10 min. After blocking, the incorporated BrdU was detected with a mouse anti-BrdU antibody (1:100, Sigma) at 4 1C overnight, followed by incubation with Alexa Fluor 555 Donkey anti-mouse IgG (1:500, Invitrogen) for 1 h. Subsequently, coverslips were mounted and observed under a fluorescent microscope (AXIO SCOPE A1; Zeiss, Jena, Germany).
Reverse transcription-PCR and quantitative PCR Total RNA was extracted with Trizol reagent and reverse transcription-PCR was performed using an Advantage RT-for-PCR kit and PCR Master Mix kit (Fermentas, Vilnius, Lithuania) according to the manufacturer's instructions. The quantitative PCR reactions were performed using a real-time SYBR technology and on ABI Prism 7000 DNA Detection System (Applied Biosystems, Foster, CA). For each sample, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 18S RNA was also assayed as an internal control and final result were normalized to and expressed as ratios of the target gene/internal controls. The primers used in the PCR reactions are listed in Supplementary Table S2 online.
Western blot
Given the heterogeneous expression of CBS and CSE in the kidney, the whole kidney was halved in the middle. One half was used for histological studies, and the other half was homogenized for western blotting analysis. Protein samples (20-80 mg) were separated by 8-10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and transferred onto a polyvinylidene difluoride membrane (Millipore, Bedford, MA). After blocking in 5% milk/Tris-buffered saline and Tween-20 buffer, membranes were individually incubated with antibodies against proteins of interest at an appropriate dilution (a-SMA (1:1000), fibronectin (1:500), CBS(1:500), CSE (1:250), ERK/phospho-ERK (1:500), JNK/phospho-JNK (1:500), P38/phospho-P38 (1:500), phospho-Smad3 (1:500), PCNA (1:1000), and c-Myc (1:1000)) at 4 1C overnight. Membranes were then washed and incubated with appropriate horseradish peroxidase-conjugated secondary antibody for 1 h. Visualization was carried out using an advanced chemiluminescence kit (GE Healthcare, Buckinghamshire, UK). The band density was quantified by ImageJ software (Bethesda, MD). GAPDH or b-actin was used as an internal control.
Statistical analysis
All data are presented as mean ± s.e.m. Statistical significance was determined using Student's t-test or one-way analysis of variance followed by a post hoc analysis (Tukey's test) where applicable. The significance level was set at Po0.05.
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